Trials
Search / Trial NCT05659433

Contrast-enhanced vs. B-mode Ultrasound-guided Percutaneous Biopsy of Retroperitoneal Tumors

Launched by IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY · Dec 12, 2022

Apply for Trial

Trial Information

Current as of February 05, 2025

Completed

Keywords

Percutaneous Biopsy Contrast Enhanced Ultrasonography Ceus Retroperitoneal Neoplasms

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • All patients with retroperitoneal tumors with indication for percutaneous biopsy
  • Exclusion Criteria:
  • • Tumors inaccessible for ultrasound guided biopsy
  • • Standard contraindications for biopsy (altered coagulation tests, poor performance status)
  • • Lack of written informed consent

Trial Officials

Zeno Spârchez, MD, Prof.

Study Chair

Prof. Dr. O. Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca

About Iuliu Hatieganu University Of Medicine And Pharmacy

Iuliu Hatieganu University of Medicine and Pharmacy is a prestigious academic institution located in Cluj-Napoca, Romania, renowned for its commitment to advancing medical education and research. As a clinical trial sponsor, the university leverages its extensive expertise in medical sciences and collaborative networks to facilitate innovative research initiatives aimed at improving healthcare outcomes. With a focus on ethical standards and regulatory compliance, the university fosters a dynamic environment for clinical investigations that contribute to the development of new therapies and enhance patient care. Its multidisciplinary approach and dedication to scientific excellence position it as a leading entity in the field of medical research.

Locations

Cluj Napoca, Cluj County, Romania

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials